{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:50:51Z","timestamp":1743382251683},"reference-count":51,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,4,1]]},"abstract":"<jats:p>We examined the effects of recombinant human (rh) insulin-like growth factor I (IGF-I) vs. rhGH in a variety of metabolic paths in a group of eight severely GH-deficient young adults using an array of contemporary tools. Protein, glucose, and calcium metabolism were studied using stable labeled tracer infusions of l-[1-13C]leucine,[ 6,6-2H2]glucose, and 42Ca and 44Ca; substrate oxidation rates were assessed using indirect calorimetry; muscle strength was determined by isokinetic and isometric dynamometry of the anterior quadriceps, as well as growth factors, hormones, glucose, and lipid concentrations in plasma before and after 8 weeks of rhIGF-I (60 \u03bcg\/kg, sc, twice daily), followed by 4 weeks of washout, then 8 weeks of rhGH (12.5 \u03bcg\/kg\u00b7day, sc); the treatment order was randomized.<\/jats:p>\n               <jats:p>In the doses administered, rhIGF-I and rhGH both increased fat-free mass and decreased the percent fat mass, with a more robust decrease in the percent fat mass after rhGH; both were associated with an increase in whole body protein synthesis rates and a decrease in protein oxidation. Neither hormone affected isokinetic or isometric measures of skeletal muscle strength. However, rhGH was more potent than rhIGF-I at increasing lipid oxidation rates and improving plasma lipid profiles. Both hormones increased hepatic glucose output, but rhGH treatment was also associated with decreased carbohydrate oxidation and increased glucose and insulin concentrations, indicating subtle insulin resistance. Neither hormone significantly affected bone calcium fluxes, supporting the concept that these hormones, by themselves, are not pivotal in bone calcium metabolism. In conclusion, rhIGF-I and rhGH share common effects on protein, muscle, and calcium metabolism, yet have divergent effects on lipid and carbohydrate metabolism in the GH-deficient state. These differences may allow for better selection of treatment modalities depending on the choice of desired effects in hypopituitarism.<\/jats:p>","DOI":"10.1210\/jcem.85.4.6541","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:32Z","timestamp":1389200732000},"page":"1686-1694","source":"Crossref","is-referenced-by-count":8,"title":["Insulin-Like Growth Factor I and Growth Hormone (GH) Treatment in GH-Deficient Humans: Differential Effects on Protein, Glucose, Lipid, and Calcium Metabolism1"],"prefix":"10.1210","volume":"85","author":[{"given":"Nelly","family":"Mauras","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Nemours Children\u2019s Clinic and Research Programs (N.M., S.W., A.R.), Jacksonville, Florida 32207"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly O.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"The Johns Hopkins School of Public Health and Hygiene (K.O.O.), Baltimore, Maryland 21205-2179"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Welch","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Nemours Children\u2019s Clinic and Research Programs (N.M., S.W., A.R.), Jacksonville, Florida 32207"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Rini","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Nemours Children\u2019s Clinic and Research Programs (N.M., S.W., A.R.), Jacksonville, Florida 32207"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Helgeson","sequence":"additional","affiliation":[{"name":"Baptist Medical Center Physical Therapy Department (K.H.), Jacksonville, Florida 32207"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Vieira","sequence":"additional","affiliation":[{"name":"National Institutes of Health (N.E.V., A.L.Y.), Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred L.","family":"Yergey","sequence":"additional","affiliation":[{"name":"National Institutes of Health (N.E.V., A.L.Y.), Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071619144315200_R1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF00866769","article-title":"Metabolic effects of recombinant human insulin-like growth factor I in humans: comparison with recombinant human growth hormone.","volume":"10","author":"Mauras","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"2020071619144315200_R2","first-page":"629","article-title":"Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.","volume":"82","author":"Guevara-Aguirre","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/1043-2760(94)P3205-L","article-title":"Growth in growth hormone insensitivity.","volume":"5","author":"Rosenbloom","year":"1994","journal-title":"Trends Endocrinol Metab"},{"key":"2020071619144315200_R4","first-page":"869","article-title":"rhIGF-I enhances whole body protein anabolism and significantly diminishes the protein-catabolic effects of prednisone in humans, without a diabetogenic effect.","volume":"80","author":"Mauras","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R5","first-page":"2633","volume":"80","year":"1995"},{"key":"2020071619144315200_R6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198707163170303","article-title":"Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults.","volume":"317","author":"Guler","year":"1987","journal-title":"N Engl J Med"},{"key":"2020071619144315200_R7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","article-title":"Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.","volume":"42","author":"Fowelin","year":"1993","journal-title":"Metabolism"},{"key":"2020071619144315200_R8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(86)80856-0","article-title":"Specific binding of human growth hormone but not insulin-like growth factors by human adipocytes.","volume":"205","author":"DiGirolamo","year":"1986","journal-title":"FEBS Lett"},{"key":"2020071619144315200_R9","first-page":"55","article-title":"Growth hormone and bone.","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocr Rev"},{"key":"2020071619144315200_R10","first-page":"8","article-title":"The effect of GH treatment on bone remodeling in GH-deficient men.","volume":"4","author":"Bravenboer","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071619144315200_R11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture rates in adults with GH deficiency.","volume":"137","author":"Rose","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071619144315200_R12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI116212","article-title":"Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.","volume":"91","author":"Kupfer","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1172\/JCI117427","article-title":"Comparison of the effects of GH and IGF-I on substrate oxidation and on insulin sensitivity in GH-deficient humans.","volume":"94","author":"Hussain","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/03008208909023897","article-title":"IGF and bone.","volume":"20","author":"McCarthy","year":"1989","journal-title":"Connect Tissue Res"},{"key":"2020071619144315200_R15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/endo-124-1-301","article-title":"Regulatory effects of IGF-I and II on bone collagen synthesis in rat calvarial cultures.","volume":"124","author":"McCarthy","year":"1989","journal-title":"Endocrinology"},{"key":"2020071619144315200_R16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI118137","article-title":"Effects of rhIGF-I administration on bone turnover during short-term fasting.","volume":"96","author":"Grinspoon","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R17","first-page":"1886","article-title":"Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength and adiposity.","volume":"83","author":"Mauras","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R18","first-page":"E1010","article-title":"Heated dorsal hand vein sampling for metabolic studies: a reappraisal","volume":"263","author":"Copeland","year":"1992","journal-title":"Am J Physiol."},{"key":"2020071619144315200_R19","first-page":"E349","article-title":"rhIGF-I administration in man: differential sensitivity to the metabolic effects of subcutaneous (SC) bolus vs","volume":"272","author":"Mauras","year":"1997","journal-title":"continuous delivery. Am J Physiol."},{"key":"2020071619144315200_R20","first-page":"E385","article-title":"Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis","volume":"257","author":"Horber","year":"1989","journal-title":"Am J Physiol."},{"key":"2020071619144315200_R21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0003-2697(84)90431-7","article-title":"Use of t-butyldimethyl silyation in gas chromatographic mass spectrometric analysis of physiologic compounds found in plasma using electron impact ionization.","volume":"141","author":"Schwenk","year":"1984","journal-title":"Anal Biochem"},{"key":"2020071619144315200_R22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/bms.1200060809","article-title":"A microprocessor controlled mass spectrometer for the fully automated purification and isotopic analysis of breath CO20.","volume":"6","author":"Schoeller","year":"1979","journal-title":"Biomed Mass Spectrom"},{"key":"2020071619144315200_R23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1139\/y90-147","article-title":"Recent studies of human calcium metabolism using stable isotope tracers.","volume":"68","author":"Yergey","year":"1990","journal-title":"Can J Physiol Pharmacol"},{"key":"2020071619144315200_R24","first-page":"E646","article-title":"Use of reciprocal pool specific activities to model leucine metabolism in humans","volume":"249","author":"Schwenk","year":"1985","journal-title":"Am J Physiol"},{"key":"2020071619144315200_R25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1203\/00006450-199106010-00018","article-title":"Dual tracer stable isotopic assessment of calcium absorption and endogenous fecal excretion in low birth weight infants.","volume":"29","author":"Abrams","year":"1991","journal-title":"Pediatr Res"},{"key":"2020071619144315200_R26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jbmr.5650070307","article-title":"Developmental changes in calcium kinetics in children assessed using stable isotopes.","volume":"7","author":"Abrams","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2020071619144315200_R27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1172\/JCI105629","article-title":"Multicompartmental analysis of calcium kinetics in normal adult males.","volume":"46","author":"Neer","year":"1967","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R28","author":"Berman","year":"1990"},{"key":"2020071619144315200_R29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00005176-199105000-00010","article-title":"Stable isotopic measurement of endogenous fecal calcium excretion in children.","volume":"12","author":"Abrams","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020071619144315200_R30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0026-0495(88)90110-2","article-title":"The theoretical bases of indirect calorimetry: a review.","volume":"37","year":"1988","journal-title":"Metabolism"},{"key":"2020071619144315200_R31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1079\/BJN19740060","article-title":"Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.","volume":"32","author":"Durnin","year":"1974","journal-title":"Br J Nutr"},{"key":"2020071619144315200_R32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI114694","article-title":"Human growth hormone prevents the protein catabolic side effects of prednisone in humans.","volume":"86","author":"Horber","year":"1990","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R33","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1172\/JCI112240","article-title":"Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in post-absorptive men.","volume":"76","author":"Fukagawa","year":"1985","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R34","first-page":"1900","article-title":"Ovarian hyperandrogenism is associated with insulin resistance to both peripheral carbohydrate and whole body protein metabolism in post pubertal young females: a metabolic study.","volume":"83","author":"Mauras","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R35","first-page":"4344","article-title":"How is whole body protein turnover perturbed in growth hormone-deficient adults?","volume":"83","author":"Hoffman","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem.83.2.4545","article-title":"A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.","volume":"83","author":"Lucidi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R37","first-page":"481","article-title":"GH and the IGF system in myogenesis.","volume":"17","author":"Florini","year":"1996","journal-title":"Endocr Rev"},{"key":"2020071619144315200_R38","first-page":"E268","article-title":"Effect of GH and resistance exercise on muscle growth and strength in older men","volume":"000","author":"Yarasheski","year":"1995","journal-title":"Am J Physiol."},{"key":"2020071619144315200_R39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1152\/jappl.1991.70.2.688","article-title":"Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength.","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"key":"2020071619144315200_R40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R41","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1172\/JCI117049","article-title":"Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone.","volume":"93","author":"Mauras","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R42","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(97)90078-0","article-title":"Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner\u2019s syndrome: a calcium kinetic study.","volume":"46","author":"Mauras","year":"1997","journal-title":"Metabolism"},{"key":"2020071619144315200_R43","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1210\/jcem.82.6.3982","article-title":"The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men [published erratum appears in J Clin Endocrinol Metab 1997 Jul;82(7):2238].","volume":"82","author":"Bravenboer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R44","first-page":"3864","article-title":"Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R45","first-page":"2222","article-title":"Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.","volume":"81","author":"Mauras","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619144315200_R46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1359\/jbmr.1999.14.4.577","article-title":"Profound hypogonadism has significant negative effects on calcium balance in males: a calcium kinetic study.","volume":"14","author":"Mauras","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071619144315200_R47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ki.1993.57","article-title":"Effects of insulin-like growth factor I on renal function in normal men.","volume":"43","author":"Hirschberg","year":"1993","journal-title":"Kidney Int"},{"key":"2020071619144315200_R48","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1172\/JCI116828","article-title":"Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.","volume":"92","author":"Hussain","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071619144315200_R49","first-page":"E579","article-title":"Pharmacokinetics of insulin-like growth factor-1 in hypopituitarism: correlation with binding proteins","volume":"277","author":"Mauras","year":"1999","journal-title":"Am J Physiol."},{"key":"2020071619144315200_R50","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions.","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071619144315200_R51","first-page":"2836","volume":"83","author":"Chapman","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/4\/1686\/10403313\/jcem1686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/4\/1686\/10403313\/jcem1686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:20:35Z","timestamp":1594959635000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/4\/1686\/2855771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,1]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.4.6541","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,1]]}}}